Abstract
Background
Ankylosing spondylitis (AS), a rheumatic disease, incapacitates human beings during the most productive stage of their lives, causes functional disturbances, and thus affects both patients and their relatives. Disease activity, functional impairment, and efficacy of treatment are affected by various environmental and genetic factors, one of which is smoking. We investigated smoking’s effect on clinical activity and functional impairment in AS.
Patients and methods
Forty-eight patients with back pain and limited movements, diagnosed with AS based on clinical, radiological, and laboratory examinations and referred to the Trakya University School of Medicine Physical Medicine and Rehabilitation Department in Turkey were included in this study. Disease activity was evaluated with the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and functional impairment with the Bath Ankylosing Spondylitis Functional Index (BASFI). The Mann-Whitney U test was used to determine relationships between smoking and physical findings, laboratory results, and BASDAI and BASFI scores.
Results
Twenty-four patients were smokers. They had significantly higher BASDAI and BASFI scores and significantly lower forced vital capacity values than nonsmokers (P=0.000, P=0.002, and P=0.001, respectively) (Mann-Whitney U test).
Conclusion
Smoking is associated with poor clinical aspect and functional impairment in AS. The underlying mechanism can be the physical incapacity caused by smoking.
Similar content being viewed by others
References
Khan MA (1998) Ankylosing spondylitis: clinical features. In: Klippel JH, Dippe PA (eds) Rheumatology, 2nd edn, vol 1. Mosby, London, 6.16:1–10
Lipsky PE (1998) Spondyloarthropathies: etiology and pathogenesis. In: Klippel JH, Dippe PA (eds) Rheumatology, 2nd edn, vol 1. Mosby, London, 6.12:1–8
Ball GV (1993) Ankylosing spondylitis. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions, 12th edn, vol 1. Lea and Febiger, Malvern, 59:1051–1060
Wolheim FA (1993) Ankylosing spondylitis. In: Kelley WN, Harris ED, Ruddy S, Sledge C (eds) Textbook of rheumatology, 4th edn, vol 1. Saunders, Philadelphia, 56:943–960
Claudepierre P, Sibilia J, Roudot-Thoraval F, Flipo RM, Wendling D et al ( 1998) Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol 25:1927–1931
Moller P (1987) Seronegative arthritis—etiology and diagnosis. Scand J Rheumatol Suppl 66:119–127
Anonymous (1988) Public health survey on smoking. PIAR
Garret S, Jenkinson T, Kennedy G, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291
Calin A, Garret S, Whitlock H, Kennedy LG, O’Shea J, Mallorie P (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285
Ward MM (2002) Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol 29:1420–1425
Fergusson DM, Goodwin RD, Horwood LJ (2003) Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol Med 33:1357–1367
Berlin I, Singleton EG, Pedarriosse AM, Lancrenon S, Rames A, et al (2003) The Modified Reasons for Smoking Scale: factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers. Addiction 98:1575–1583
Arday DR, Milton MH, Husten CG, Haffer SC, Wheeless SC et al (2003) Smoking and functional status among Medicare managed care enrollees. Am J Prev Med 24:234–241
Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedic K, Dawes (1996) Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 25:138–142
Doran MF, Brophy S, MacKay K, Taylor G, Calin A (2003) Predictors of long term outcome in ankylosing spondylitis. J Rheumatol 30:316–320
Viitanen JV, Heikkila S, Kokko ML, Kautiainen H (2000) Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials? Clin Rheumatol 19:131–137
Dalyan M, Guner A, Tuncer S, Bilgic A, Arasil T (1999) Disability in ankylosing spondylitis. Disabil Rehabil 21:74–79
Spoorenberg A, Van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:961–965
Franssen MJ, Van de Putte LBA, Gribnau FWJ (1985) IgA serum levels and disease activity in ankylosing spondylitis. Ann Rheum Dis 44:766–771
Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E et al (1999) Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 26:971–974
Laurent MR, Panayi GS (1983) Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 42:524–528
Van der Heijde D, Calin A, Dougados M, Khan MA, Van der Linden S, Bellamy N et al (1999) Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. J Rheumatol 26:951–954
Fisher LR, Cawley MID, Holgate ST (1990) Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis 49:921–925
Harrison BJ, Silman AJ, Wiles NJ, Scott DG, Symmons DP (2001) The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 44:323–330
Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, Brownfield A, Alldersea J, Fryer AA, Strange RC (2002) Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 46:640–646
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaan, U., Ferda, Ö. Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis. Rheumatol Int 25, 357–360 (2005). https://doi.org/10.1007/s00296-004-0451-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-004-0451-3